The highlights of Afternoons with Relebogile Mabotja, just in case you missed the show.

The highlights of Afternoons with Relebogile Mabotja, just in case you missed the show.

Afternoons with Relebogile Mabotja

Highlights from 702 Afternoons with Relebogile Mabotja, just in case you missed the show.

Highlights from 702 Afternoons with Relebogile Mabotja, just in case you missed the show.

Unplugged on 702 Afternoons with Tubatsi Moloi

Episode 3: Health-Developed a candidate vaccine for TB using a gene-editing approach. 



Relebogile Mabotja speaks to Prof. Bavesh Davandra Kanathe Director of Research Unit, Head of School: Pathology at the University of the Witwatersrand about a potential vaccine to prevent TB in people of all ages.

Episode 3: Health-Developed a candidate vaccine for TB using a gene-editing approach. 
 
Relebogile Mabotja speaks to Prof. Bavesh Davandra Kana the Director of Research Unit, Head of School: Pathology at the University of the Witwatersrand about a potential vaccine to prevent TB in people of all ages.

The Series Edition on types of innovative research in science-Episode 3

Relebogile Mabotja speaks to Dr. Natalie Raphilthe Founder  & Chief Technology Officer of  Robots Can Think about AI in chronic illness about a first in Africa which is called Anixi Health it houses all chronic illness types and provides community support to the chronically ill.

Relebogile Mabotja speaks to Dr. Natalie Raphil the Founder  &amp; Chief Technology Officer of  Robots Can Think about AI in chronic illness about a first in Africa which is called Anixi Health it houses all chronic illness types and provides community support to the chronically ill.

Tech Feature: AI in chronic illness - Human intelligence + Artificial intelligence

Listeners respond to Relebogile Mabotja's open line question.

Listeners respond to Relebogile Mabotja's open line question.

Unplugged on 702 Afternoons with Tubatsi Moloi

In 1 playlist(s)

Afternoons with Relebogile Mabotja

Social links

Follow podcast

Recent clips